Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP265001.RAeZeG-t2S9hKdm2Gi2GcpyBQebOGi1j89X59aaWLad48130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP265001.RAeZeG-t2S9hKdm2Gi2GcpyBQebOGi1j89X59aaWLad48130_assertion type Assertion NP265001.RAeZeG-t2S9hKdm2Gi2GcpyBQebOGi1j89X59aaWLad48130_head.
- NP265001.RAeZeG-t2S9hKdm2Gi2GcpyBQebOGi1j89X59aaWLad48130_assertion description "[By combining affinity proteomics and gene expression analysis, we now propose superoxide dismutase 1 (SOD1) as the most likely target of one of these small molecules, referred to as lung cancer screen 1 (LCS-1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP265001.RAeZeG-t2S9hKdm2Gi2GcpyBQebOGi1j89X59aaWLad48130_provenance.
- NP265001.RAeZeG-t2S9hKdm2Gi2GcpyBQebOGi1j89X59aaWLad48130_assertion evidence source_evidence_literature NP265001.RAeZeG-t2S9hKdm2Gi2GcpyBQebOGi1j89X59aaWLad48130_provenance.
- NP265001.RAeZeG-t2S9hKdm2Gi2GcpyBQebOGi1j89X59aaWLad48130_assertion SIO_000772 21930909 NP265001.RAeZeG-t2S9hKdm2Gi2GcpyBQebOGi1j89X59aaWLad48130_provenance.
- NP265001.RAeZeG-t2S9hKdm2Gi2GcpyBQebOGi1j89X59aaWLad48130_assertion wasDerivedFrom befree-20140225 NP265001.RAeZeG-t2S9hKdm2Gi2GcpyBQebOGi1j89X59aaWLad48130_provenance.
- NP265001.RAeZeG-t2S9hKdm2Gi2GcpyBQebOGi1j89X59aaWLad48130_assertion wasGeneratedBy ECO_0000203 NP265001.RAeZeG-t2S9hKdm2Gi2GcpyBQebOGi1j89X59aaWLad48130_provenance.